Adherence to advanced therapies in inflammatory bowel diseases: Real-world rates and predictors of non-adherence
Authors:
- Elena De CristofaroECElena De Cristofaro
- Luca BasileLBLuca Basile
- Francesca ZorziFZFrancesca Zorzi
- Elisa CuccagnaECElisa Cuccagna
- Alice ColellaACAlice Colella
- Laura DoniLDLaura Doni
- Michele LucarelliMLMichele Lucarelli
- Irene MarafiniIMIrene Marafini
- Giovanni MonteleoneGMGiovanni Monteleone
- Emma CalabreseECEmma Calabrese
Open Access
- 9 October 2026
- journal article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 58 (12) , 1569-1574
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Therapeutic adherence in inflammatory bowel disease: User guide from a multidisciplinary modified Delphi consensusDigestive and Liver Disease, 2025
- Designing for medication adherence in inflammatory bowel disease: multi-disciplinary approaches for self-administrable biotherapeuticseClinicalMedicine, 2024
- Crohn's diseaseThe Lancet, 2024
- Utility of the MARS-5 in Assessing Medication Adherence in IBDInflammatory Bowel Diseases, 2021
- Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2019
- Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel diseaseJGH Open, 2019
- Factors Associated With Non-Adherence to Oral Medication for Inflammatory Bowel Disease: A Systematic ReviewAmerican Journal of Gastroenterology, 2010
- A Systematic Prospective Comparison of Noninvasive Disease Activity Indices in Ulcerative ColitisClinical Gastroenterology and Hepatology, 2009
- Compliance to Therapy in Patients on a Maintenance Dose of SulfasalazineJournal of Clinical Gastroenterology, 1982
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980